<?xml version="1.0" encoding="UTF-8"?>
<p>Patients were included in the cohort between December 19, 2013, and December 4, 2014. Inclusion criteria were: age ≥ 16 years of age, ability to sign informed consent, blood sample positive for CHIKV RNA via qRT-PCR, and onset of symptoms (headache, arthralgia, myalgia, fever, rash, fatigue) ≤7 days.</p>
